Atorvastatin & Aspirin and Clopidogrel Tablets

Product Composition & Strength

We supply this product typically in a Capsule-in-Capsule or Multi-Particulate Tablet format to ensure the chemical stability of the three distinct APIs.

Healthy Inc is a specialized global supplier and exporter of advanced cardiology, critical care, and targeted cardiovascular therapeutics. We provide ultra-high-purity, kinetically balanced Atorvastatin, Aspirin & Clopidogrel FDC, manufactured in WHO–GMP certified, high-precision oral solid dosage facilities. This "Triple Therapy Poly-Pill" is a massive-volume strategic export to cardiac centers, stroke units, and government health ministries, serving as the globally mandated intervention for Secondary Prevention of Myocardial Infarction (Heart Attack) and Ischemic Stroke.

Product Overview

This formulation operates as a "Triple-Shield" against arterial blockage. By combining a potent lipid-lowering agent with two different types of blood thinners, the FDC stabilizes existing plaques while physically preventing the formation of new life-threatening clots.

• Mechanism 1 (Plaque Stabilization - Atorvastatin): As an HMG-CoA Reductase Inhibitor, Atorvastatin lowers LDL (bad cholesterol). More importantly, it "pleiotropically" stabilizes the fibrous cap of existing arterial plaques, preventing them from rupturing.

• Mechanism 2 (COX-1 Inhibition - Aspirin): Aspirin irreversibly inhibits the Cyclooxygenase-1 (COX-1) enzyme. This blocks the production of Thromboxane A2, a powerful chemical that tells platelets to stick together.

• Mechanism 3 (P2Y12 Blockade - Clopidogrel): Clopidogrel is a prodrug that inhibits the P2Y12 ADP receptor on platelets. By blocking a different pathway than Aspirin, it provides "Dual Anti-Platelet Therapy" (DAPT), making it nearly impossible for a clot to form on a damaged vessel wall or stent.

Technical & Logistics Specifications

• HS Code: 3004.90.69 (Medicaments containing other active substances - Cardiovascular)

• CAS Numbers: 134523-03-8 (Atorvastatin) / 50-78-2 (Aspirin) / 113665-84-2 (Clopidogrel)

• Dosage Form: Capsule or Film-Coated Tablet

• Packaging: Alu-Alu Blisters (MANDATORY). This combination is highly sensitive to moisture and light; our moisture-lock packaging ensures 24-month stability in Zone IVb tropical climates.

Manufacturing Authority & Compliance

• Enteric-Coating Mastery: Our Aspirin component is Enteric-Coated (Gastro-resistant). This ensures the drug passes through the stomach and dissolves only in the intestine, drastically reducing the risk of gastric ulcers and internal bleeding.

• Stability Validation: We utilize advanced analytical techniques to ensure zero interaction between Atorvastatin calcium and the acidic environment of Aspirin, maintaining 100% potency of all three ingredients.

Primary Indications

• Cardiology: Secondary prevention of Myocardial Infarction (Heart Attack) in patients with established coronary artery disease.

• Neurology: Prevention of recurrent Ischemic Stroke or Transient Ischemic Attack (TIA).

• Post-Surgical: Essential maintenance therapy for patients with coronary stents (Drug-Eluting Stents).

Dosage & Administration

• Standard Adult Dosing: 1 capsule/tablet once daily, preferably in the evening (when cholesterol synthesis is highest).

• Administration: Must be swallowed whole. Do not crush or chew, as this destroys the enteric coating and leads to gastric irritation.

Safety Warning: Bleeding Risk. Patients must be monitored for signs of internal bleeding (black stools, easy bruising). Use with extreme caution in patients with active peptic ulcers or severe hepatic impairment. Avoid co-administration with other NSAIDs.

Global Export & Contract Manufacturing

Healthy Inc is a premier Cardiovascular Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for specialized Cardiac Poly-Pills. Whether you are a Cardiac Hospital Network in Africa or a B2B Pharma Marketplace partner in the CIS, we ensure secure, WHO-GMP compliant delivery.